CTOR Competitors & Alternatives

Compare Citius Oncology, Inc. with similar stocks in the same industry

Drug Manufacturers - Specialty & Generic

CTOR

Main Stock
$0.75
Tradestie Score
41
Market Cap
$164.52M
Analyst Upside
+433.3%

Top Competitors

48 stocks in Drug Manufacturers - Specialty & Generic
Company Price Market Cap P/E Score Action
AQST Aquestive Therapeutics, Inc. Common Stock
$4.80
$711.32M - 34 Compare
ESPR Esperion Therapeutics, Inc.
$3.18
$584.71M - 53 Compare
ETON Eton Pharmaceutcials, Inc. Common Stock
$64.43
$543.32M 162.7 36 Compare
EOLS Evolus, Inc. Common Stock
$8.78
$397.82M - 33 Compare
IRWD Ironwood Pharmaceuticals, Inc. - Class A
$4.13
$237.15M 5.4 50 Compare
SLXN Silexion Therapeutics Corp Ordinary Shares
$0.37
$11.85M - 49 Compare
VSEE VSee Health, Inc. Common Stock
$0.05
$10.25M - 42 Compare
IBO Impact BioMedical, Inc.
$0.45
$7.84M 0.5 50 Compare
PLRZ Polyrizon Ltd. Ordinary Shares
$10.70
$6.53M - 52 Compare
NIVF NewGenIvf Group Limited Class A ordinary shares
$0.49
$4.04M 0.0 48 Compare

Data updated: Aug 24, 2026 | Industry: Drug Manufacturers - Specialty & Generic (SIC 2834)

48 stocks in this industry